Literature DB >> 19858430

Going off-label without venturing off-course: evidence and ethical off-label prescribing.

Emily A Largent1, Franklin G Miller, Steven D Pearson.   

Abstract

Mesh：

Year:  2009        PMID： 19858430     DOI： 10.1001/archinternmed.2009.314

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  10 in total

1.  Attitudes, knowledge and views on off-label prescribing in children among healthcare professionals in Malaysia.

Authors:  Shamala Balan; Mohamed Azmi Ahmad Hassali; Vivienne S L Mak
Journal:  Int J Clin Pharm       Date:  2019-06-13

2.  Neurofeedback as placebo: a case of unintentional deception?

Authors:  Louiza Kalokairinou; Laura Specker Sullivan; Anna Wexler
Journal:  J Med Ethics       Date:  2021-09-14       Impact factor: 5.926

3.  OncoKB: A Precision Oncology Knowledge Base.

Authors:  Debyani Chakravarty; Jianjiong Gao; Sarah M Phillips; Ritika Kundra; Hongxin Zhang; Jiaojiao Wang; Julia E Rudolph; Rona Yaeger; Tara Soumerai; Moriah H Nissan; Matthew T Chang; Sarat Chandarlapaty; Tiffany A Traina; Paul K Paik; Alan L Ho; Feras M Hantash; Andrew Grupe; Shrujal S Baxi; Margaret K Callahan; Alexandra Snyder; Ping Chi; Daniel Danila; Mrinal Gounder; James J Harding; Matthew D Hellmann; Gopa Iyer; Yelena Janjigian; Thomas Kaley; Douglas A Levine; Maeve Lowery; Antonio Omuro; Michael A Postow; Dana Rathkopf; Alexander N Shoushtari; Neerav Shukla; Martin Voss; Ederlinda Paraiso; Ahmet Zehir; Michael F Berger; Barry S Taylor; Leonard B Saltz; Gregory J Riely; Marc Ladanyi; David M Hyman; José Baselga; Paul Sabbatini; David B Solit; Nikolaus Schultz
Journal:  JCO Precis Oncol       Date:  2017-05-16

4.  Ethical issues in new drug prescribing.

Authors:  Lindsay W Cole; Jennifer C Kesselheim; Aaron S Kesselheim
Journal:  J Bioeth Inq       Date:  2011-12-15       Impact factor: 1.352

5.  Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.

Authors:  Jenna Wong; Aude Motulsky; Michal Abrahamowicz; Tewodros Eguale; David L Buckeridge; Robyn Tamblyn
Journal:  BMJ       Date:  2017-02-21

6.  Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making.

Authors:  Yves S J Aquino; Nicolo Cabrera
Journal:  J Med Ethics       Date:  2020-07-09       Impact factor: 2.903

Review 7.  Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification.

Authors:  Octav Ginghina; Ariana Hudita; Marius Zamfir; Andrada Spanu; Mara Mardare; Irina Bondoc; Laura Buburuzan; Sergiu Emil Georgescu; Marieta Costache; Carolina Negrei; Cornelia Nitipir; Bianca Galateanu
Journal:  Front Oncol       Date:  2022-03-08       Impact factor: 6.244

8.  Guideline for the management of pediatric off-label use of drugs in China (2021).

Authors:  Min Meng; Enmei Liu; Bo Zhang; Quan Lu; Xiaobo Zhang; Bin Ge; Ye Wu; Li Wang; Mo Wang; Zhengxiu Luo; Ziyu Hua; Xiaoling Wang; Wei Zhao; Yi Zheng; Xinan Wu; Ruiling Zhao; Wenbo Meng; Li Xiang; Gang Wang; Yuntao Jia; Yongchuan Chen; Xiaoyan Dong; Lina Hao; Chengjun Liu; Meng Lv; Xufei Luo; Yunlan Liu; Quan Shen; Wenjuan Lei; Ping Wang; Yajia Sun; Juanjuan Zhang; Ling Wang; Ruobing Lei; Tianchun Hou; Bo Yang; Qiu Li; Yaolong Chen
Journal:  BMC Pediatr       Date:  2022-07-23       Impact factor: 2.567

9.  Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.

Authors:  Claire M Erickson; Lindsay R Clark; Fred B Ketchum; Nathaniel A Chin; Carey E Gleason; Emily A Largent
Journal:  Alzheimers Dement (Amst)       Date:  2022-08-25

10.  Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.

Authors:  Sibel Ascioglu; K Arnold Chan
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.